The relationship between the quantitative evaluation of thyroid bed uptake and the disappearance of accumulation in adjuvant radioactive iodine therapy for differentiated thyroid cancer

[1] Dong F(2019)Standardized uptake value using thyroid quantitative SPECT/CT for the diagnosis and evaluation of graves’ disease: a prospective multicenter study Biomed Res Int. 3 8-133

[2] Li L(2019)Does quantification have a role to play in the future of bone SPECT? Eur J Hybrid Imaging. 3 10-1214

[3] Bian Y(2019)ROC study and SUV threshold using quantitative multi-modal SPECT for bone imaging Eur J Hybrid Imaging. 57 1422-20

[4] Li G(2015)Evaluation of quantitation accuracy for xSPECT IEEE Nucl Sci Symp Conf Rec 6 342-1441

[5] Han X(2016)Therapeutic response assessment of bone metastatic prostate carcinoma treated by abiraterone using x-SPECT Quant®: preliminary results J Nucl Med. 21 1-458

[6] Li M(2019)Feasibility study and preliminary results of prognostic value of bone SPECT-CT quantitative indices for the response assessment of bone metastatic prostate carcinoma to abiraterone Front Med. 19 1167-282

[7] Ross JC(2016)2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer Thyroid. 36 16-510

[8] Vilić D(2009)Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid. 88 1433-undefined

[9] Sanderson T(2015)18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers Nucl Med Commun. 48 452-undefined

[10] Vöö S(2003)A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma J Clin Endocrinol Metab. 33 275-undefined

[1] Dong F(2019)Standardized uptake value using thyroid quantitative SPECT/CT for the diagnosis and evaluation of graves’ disease: a prospective multicenter study Biomed Res Int. 3 8-133

[2] Li L(2019)Does quantification have a role to play in the future of bone SPECT? Eur J Hybrid Imaging. 3 10-1214

[3] Bian Y(2019)ROC study and SUV threshold using quantitative multi-modal SPECT for bone imaging Eur J Hybrid Imaging. 57 1422-20

[4] Li G(2015)Evaluation of quantitation accuracy for xSPECT IEEE Nucl Sci Symp Conf Rec 6 342-1441

[5] Han X(2016)Therapeutic response assessment of bone metastatic prostate carcinoma treated by abiraterone using x-SPECT Quant®: preliminary results J Nucl Med. 21 1-458

[6] Li M(2019)Feasibility study and preliminary results of prognostic value of bone SPECT-CT quantitative indices for the response assessment of bone metastatic prostate carcinoma to abiraterone Front Med. 19 1167-282

[7] Ross JC(2016)2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer Thyroid. 36 16-510

[8] Vilić D(2009)Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid. 88 1433-undefined

[9] Sanderson T(2015)18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers Nucl Med Commun. 48 452-undefined

[10] Vöö S(2003)A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma J Clin Endocrinol Metab. 33 275-undefined